Codexis to Participate in TD Cowen 46th Annual Health Care Conference

Core Insights - Codexis, Inc. is a leading provider of enzymatic solutions for the manufacturing of complex therapeutics and will attend the TD Cowen 46 Annual Health Care Conference from March 2-4, 2026 [1] - The company will participate in a fireside chat on March 3, 2026, at 11:50 am ET, with a live webcast available on its Investor Relations website [2] Company Overview - Codexis leverages its proprietary CodeEvolver technology platform to discover, develop, and enhance high-performance enzymes for efficient and scalable therapeutics manufacturing [3] - The company is developing the ECO Synthesis manufacturing platform to enable the scaled manufacture of RNAi therapeutics through an enzymatic route [3] - Codexis enzymes provide improvements such as higher yields, reduced energy usage, lower waste generation, enhanced manufacturing efficiency, and greater sensitivity in genomic and diagnostic applications [3]